pharmeasy: PharmEasy value crash may not hit Velumani's stake

PharmEasy is faced with a steep cut in its valuation, with the new funding round pegging its shares at Rs 5 each compared to the Rs 50 per share that it secured in 2021. The huge fall in value has triggered questions about the fate of Velumanis purchase of a 5% stake in the firm in 2021 when it was valued at $4 billion.

Related Keywords

Manipal ,Karnataka ,India ,Bombay ,Maharashtra ,Mumbai ,Dharmil Sheth ,Thyrocare Ettech ,Dhaval Shah ,Siddharth Shah ,Ranjan Pai ,Arokiaswamy Velumani ,Hardik Dedhia ,Manipal Group ,Temasek ,Bombay High Court ,Prosus Ventures ,Harsh Parekh ,Pharmeasy ,Thyrocare ,Tpg ,Goldman Sachs ,Api Holdings ,